Education
About Us
Working with TipRanks
Follow Us
Joel Ackerman Insider Profile
11 Followers
Joel Ackerman, Director at Kindred Healthcare, holds 148.44K shares in DaVita (Ticker: DVA), holds 1.06M shares in Champions Oncology (Ticker: CSBR), holds 0.00 shares in Kindred Healthcare (Ticker: KND).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+34.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Joel Ackerman holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Oct 03, 2018 - Oct 03, 2019
Return:+59.10%
The most profitable trade made by Joel Ackerman
Joel Ackerman's Trading History
Kindred Healthcare
May 25, 2017
―
Uninformative Buy
―
$0.00
DaVita
Feb 09, 2026
CFO and Treasuer
Uninformative Buy
4.24M
$21.87M
Champions Oncology
Nov 06, 2025
Director
Uninformative Buy
198.25K
$6.39M
List of latest transactions for each holding click on a transaction to see Joel Ackerman's performance on stock
You May Also Like
Joel Ackerman insider profile FAQ
What is the percentage of profitable transactions made by Joel Ackerman?
The percentage of profitable transactions made by Joel Ackerman is 100%.
What is the average return per transaction made by Joel Ackerman?
The average return per transaction made by Joel Ackerman is 34.90%.
What stocks does Joel Ackerman hold?
Joel Ackerman holds: KND, DVA, CSBR stocks.
What was Joel Ackerman’s latest transaction?
Joel Ackerman latest transaction was an Uninformative Buy of $4.24M.
What was Joel Ackerman's most profitable transaction?
Joel Ackerman’s most profitable transaction was an Informative Sell of CSBR stock on October 3, 2018. The return on the trade was 59.10%.
What is Joel Ackerman's role in Kindred Healthcare?
Joel Ackerman's role in Kindred Healthcare is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.